Folic acid awareness and usage among females at Saudi Electronic University in Jeddah,Saudi Arabia

Abstract

Objectives:

This study evaluates awareness of folic acid and neural tube defects, use of folic acid and knowledge of folic acid usage among female university students in Saudi Arabia.

Methods:

An analytical cross-sectional survey was conducted in the Jeddah branch of Saudi Electronic University. A total of 400 female students in the 19–45 years age group were contacted to participate in the study using a convenience sampling method. Eighty-eight students refused to participate, so 312 students were included in the study. Demographic characteristics of participants and their awareness, usage and knowledge of folic acid are presented as frequencies and percentages. Logistic regression analysis was used to compute crude odds ratios to show the association between demographic factors and knowledge of folic acid supplementation. A further adjusted odds ratio was calculated to control for other cofactors. A p-value < 0.05 was considered significant.

Results:

Overall, 81.1% (253/312) of respondents had heard of folic acid, 30.4% knew about neural tube defects, and 47.1% of respondents reported using folic acid supplements. Marriage was found to be associated with awareness of folic acid (adjusted odds ratio (95% confidence interval) = 2.64 (1.01–6.91)). Health sciences specialization and experience of pregnancy were associated with the usage of folic acid (adjusted odds ratio (95% confidence interval) = 3.46 (1.73–6.91) and adjusted odds ratio (95% confidence interval) = 6.70 (3.09–14.53), respectively). A bachelor’s and above education level was found to be associated with knowledge of folic acid deficiency leading to neural tube defects (adjusted odds ratio (95% confidence interval) = 2.03 (1.17–3.52)), and health sciences specialization was found to be associated with knowledge of natural sources of folic acid (adjusted odds ratio (95% confidence interval) = 2.33 (1.25–4.36)). Similarly, marriage was found to be associated with knowledge of the correct dosage of folic acid and timing of folic acid to prevent neural tube defects (adjusted odds ratio (95% confidence interval) = 6.34 (3.50–11.48) and adjusted odds ratio (95% confidence interval) = 3.45 (1.93–6.16), respectively). Experience of pregnancy was found to be an associated with good total knowledge of folic acid (adjusted odds ratio (95% confidence interval) = 3.05 (1.65–5.63); p = 0.0001).

Conclusion:

The study findings highlight the lack of awareness among female university students about the importance of folic acid usage in the prevention of neural tube defects. There is a need for interventional programs in universities to create awareness.

Keywords

Awareness folic acid knowledge neural tube defects Saudi Arabia

Introduction

Folate is a member of the vitamin B family. It is essential in the generation of new cells and the synthesis of new DNA, so its demand increases during pregnancy.¹ In 1965, Hibbard and Smithells² first suggested that deficiency of folates in the maternal diet is related to the occurrence of neural tube defects (NTDs). These are abnormalities that occur during neurulation, the process that forms the neural tube and ultimately the spinal cord, brain, and central nervous system. The two most common forms of NTDs are anencephaly (total or partial absence of brain) and spina bifida (presence of bony vertebral defect), causing serious mortality and disability among infants.³ The process of neurulation is usually completed by 28 days postconception, that is, before the woman knows she is pregnant.³ A number of studies have documented that NTDs can be significantly reduced by folate supplementation in the periconceptional period,^4–6 suggesting that folate supplementation is the best way to reduce NTDs. The folic acid (FA) action mechanism is still under investigation; however, it is known that FA plays an important role in methionine synthase activity. FA provides methylation that converts homocysteine into methionine, without which homocysteine levels increase preventing the closure of neural tubes.⁷

The World Health Organization (WHO) recommends that all women take an FA supplement (400 mcg daily) from the time they start planning to conceive until 12 weeks of gestation.⁸ Furthermore, the daily dosage of FA should be increased up to 5 mg if the woman has already given birth to a child with a NTD.⁸ Busby et al.⁹ reported an overall mean decline in the prevalence of NTDs in the United Kingdom and Ireland by 32% (17%–44% decline) from 1989–1991 to 1999–2001 after the FA supplementation policy was implemented.⁹ Furthermore, a mean reduction in the prevalence of NTDs by 17% (44% decline to a 4% rise) was reported in countries (the United Kingdom, Ireland, Netherland, Switzerland, Denmark, Norway, Portugal, Malta, and Finland) that introduced the policy of raising folate levels through supplementation or diet by 1999, compared to a mean reduction in the prevalence of NTDs by 9% (26% decline to a 12% rise) in countries (France, Spain, Austria, Belgium, Croatia, Germany, and Italy), which had no government policy to improve the folate levels of pregnant women.⁹ According to a Cochrane review based on five clinical trials, FA supplementation alone or in combination with other micronutrients prevents the occurrence of NTDs (relative risk (RR) = 0.28, 95% CI = 0.15–0.52).¹⁰

However, the recommendation of periconceptional supplementation of FA in planned pregnancies is not effective, as many women may not receive or respond to health promotion messages to commence supplementation preconceptionally, or may remain unaware of dietary modifications needed to achieve sufficient folate intake.⁶ Furthermore, a large proportion of pregnancies in most countries are not planned, so women may not take FA supplements in the preconception period; thus, relying on supplementation alone is not sufficient to prevent NTDs.⁹

The folate status of most women of childbearing age can be improved through fortification of staple foods with FA, which would also help to reduce socioeconomic inequalities in the prevalence of NTDs.¹¹ The implementation of mandatory fortification of cereal grains, resulted in a 27% reduction in NTDs in the United States from 1995–1996 (prefortification) to 1999–2000 (postfortification),¹² and a reduction of 46% in Canada from 1993–1997 (prefortification) to 2000–2002 (postfortification).¹³ A meta-analysis of eight population-based observational studies examining FA food fortification (before and after) reported an estimated reduction in NTD incidence of 46% (95% CI = 37–54) and provided an estimate that FA fortification would prevent 13% of neonatal deaths attributed to congenital abnormalities in low-income countries.¹⁴ Moreover, the prevalence of spina bifida is also significantly lower in countries with mandatory FA fortification policies than in those without such policies.¹⁵

Saudi Arabia has programs that seek to reduce NTD incidences, including a national policy of the Ministry of Health and its food regulator for the mandatory fortification of flour with iron, FA, niacin, riboflavin, and thiamine starting from 2001 with the minimum requirement of 1.653% (16.53 g of FA for each kilogram of flour).¹⁶ As all flours in Saudi Arabia are produced in industrial mills, 100% coverage of fortification has been achieved.¹⁷ A decline in the incidence of NTDs was observed in Saudi Arabia from 1.9/1000 live births (1997–2000) to 0.76/1000 live births (2001–2005)¹⁸ and 0.44/1000 live births (2001–2010).¹⁹ However, a recent study by Majeed-Saidan et al.²⁰ reported an increase in NTDs to 0.90/1000 live births (2010–2013).²⁰

Studies from Saudi Arabia show inconsistency in the level of knowledge of FA supplementation among women. A few studies report that a high proportion of women are not aware of the importance of FA in preventing NTDs along with its timing,^21–24 while other studies have reported a high level of awareness among married participants regarding the use of FA supplementation before conception and its role in preventing NTDs.^25–27

The Saudi Arabia Ministry of Health website has educational content on “Planning for Pregnancy” in “Women’s Health” which describes key prepregnancy preparations such as taking 400 mcg of FA supplements daily before pregnancy and until 12 weeks of gestation.²⁸ Moreover, in Saudi Arabia, FA supplementation is easily available to the population via over-the-counter from pharmacies with or without a prescription.

The recent increase in the prevalence of NTDs in Saudi Arabia even after the fortification of flour suggests that there is a need to raise the awareness of women regarding the use of FA to reduce the occurrence of NTDs. Only one study has been conducted on university students in Saudi Arabia,²¹ and a few studies conducted on the general population also include students as participants.^23,24,26 Therefore, to fill the gap in the literature, this study was designed with a primary objective to determine the awareness, usage and knowledge levels related to FA among female university students. The secondary objective was to determine the association of demographic factors with the awareness, usage, and knowledge of participants regarding FA and NTDs. These analyses will help to identify the target population to focus on for the promotion of FA supplementation.

Materials and methods

Study area, study design, study population, inclusion criteria and exclusion criteria

An analytical cross-sectional survey was conducted among female students in the Jeddah branch of Saudi Electronic University (SEU) from March to November 2018. The inclusion criteria were female students aged 19–45 years who were willing to participate in the survey.

Sample size calculation

The sample size was calculated using the RaoSoft Sample size calculator,²⁹ taking the population (female students from all branches of specialization) size as 1500, margin of error as 5%, confidence level as 95% and response distribution as 50%. The sample size determined was 306, which was rounded to 310. Assuming, a 70% participation rate, the additional 90 participants were added to the sample size and 400 students were contacted for participation.

Sampling technique and procedure

A convenience sampling method was used to enroll the participants. The researcher contacted 400 students in the university cafeteria during breaks. Among 400 students, 88 students refused to participate in the study, and the remaining 312 (78%) students were provided the survey link for participation. The study protocol was reviewed and approved by the Institutional Review Board of Saudi Electronic University.

Study instrument and procedure

An online, close-ended, multiple-choice questionnaire was developed based on a previous study with slight modification to assess the awareness and knowledge of FA usage during pregnancy.²⁷ The first part of the questionnaire includes questions on the demographic characteristics (age, education, specialization, and marital status) and experience of pregnancy, and the second part assessed awareness, usage, and knowledge of FA. The awareness domain questions were “Have you ever heard of FA supplements” and “Have you ever heard of NTDs”; the question on FA use was “Do you take FA supplements or multivitamins containing FA prenatally or during current pregnancy regularly,” and the knowledge domain questions included “Can FA deficiency lead to NTDs,” “What is the timing of FA supplementation to prevent the occurrence of NTDs,” “What is the recommended dosage of FA,” and “What are the natural sources of FA” (Appendix 1). The researcher described the study objectives of the survey to the student. If the student agreed to participate, signed informed consent was obtained and the survey link was sent to the student on mobile devices for self-administration of the questionnaire under the researcher’s supervision.

Data management and analysis

The statistical package for social sciences (IBM SPSS version 24 software, Armonk, NY, USA) was utilized for statistical analysis. The demographic characteristics, awareness, usage of FA, and knowledge of FA are described as frequencies and percentages. Knowledge about FA was assessed using four closed-ended, multiple-choice questions. Polychotomous responses were dichotomized for analysis. Each correct answer was assigned a score of “1,” and incorrect answer as a score of “0.” The total score was calculated and considered “poor” if the score was “⩽2,” “fair” if the score was “3,” and “good” if the score was “4” for the overall knowledge level among the respondents.

The factors affecting FA awareness, FA usage, and knowledge about FA were assessed by computing crude odds ratios (ORs) and adjusted odds ratios (AORs) for other covariates (age, education level, specialization, marital status, and current or previous pregnancies) using logistic regression along with CIs. A p-value < 0.05 was considered statistically significant.

Results

Demographic characteristics of the study population

The response rate of the survey was 78% (312/400). The majority of the respondents (215, 68.9%) were in the 20–30 years age group, and almost half (160, 51.3%) were in the preparatory year of their educational course. Table 1 shows the sociodemographic characteristics of the study population.

Table 1.

Distribution of sociodemographic characteristics of total respondents, n = 312.

Characteristics	Total respondents (n = 312)
Characteristics	Frequency (n)	Percentage (%)
Age (years)
19–20	17	5.4
21–30	215	68.9
31–40	71	22.8
41–45	9	2.9
Education level
Preparatory year^a	160	51.3
Bachelor	133	42.6
Master	19	6.1
Specialization
Computing and informatics	59	18.9
Financial science and administration	124	39.7
Health sciences	81	26.0
Science and theoretical studies	36	11.6
Others	12	3.8
Marital status
Married	168	53.8
Unmarried	144	46.2
Experience of pregnancy
Current pregnancy	18	5.8
History of pregnancy	135	43.2
Never pregnant	159	51.0

One-year course in university to teach students English, basic mathematics, and computer application.

Awareness and usage of FA

The details of awareness and usage of FA are shown in Table 2. Unadjusted and adjusted (for all five demographic variables) ORs with 95% CIs for awareness about FA supplementation and its usage are presented in Table 3. The respondents above 30 years of age were found to have significantly higher awareness and usage of FA than their younger colleagues (<30 years), but when adjusted for covariates, the AOR showed no difference in the level of awareness and usage of FA between the age groups. Marriage was found to be an independent factor associated with FA awareness (AOR (95% CI) = 2.64 (1.01–6.91); p = 0.047). The usage of FA was found to be significantly higher among married respondents, but when adjusted for covariates (age, education, specialization, and current or past pregnancies), AOR showed no difference in the usage of FA for marital status. Age, health sciences specialization, and pregnancy experience were found to be independent factors associated with FA supplement usage (AOR (95% CI) = 2.10 (1.12–3.94), AOR (95% CI) = 3.46 (1.73–6.91), and AOR (95% CI) = 6.70 (3.09–14.53), respectively).

Table 2.

Distribution of awareness and usage of folic acid among total respondents, n = 312.

Variable	Total respondents (n = 312)
Variable	Frequency (n)	Percentage (%)
Have you ever heard of FA supplements?
Yes	253	81.1
No	59	18.9
Have you ever heard of neural tube defects?
Yes	95	30.4
No	171	54.8
Not sure	46	14.7
Do you take a FA supplement or vitamin containing FA regularly (at least once in a week)?
Yes	147	47.1
No	83	26.6
I don’t know	82	26.3

FA: folic acid.

Table 3.

Association of sociodemographic factors with awareness and usage of folic acid among the total respondents, n = 312.

Characteristics	Awareness about FA		OR (95% CI)p-value	AOR (95% CI)p-value	Usage of FA		OR (95% CI)p-value	AOR (95% CI)p-value
Characteristics	Yes (n = 253)	No (n = 59)	OR (95% CI)p-value	AOR (95% CI)p-value	Yes (n = 147)	No (n = 165)	OR (95% CI)p-value	AOR (95% CI)p-value
Age (years)
>30 (Ref)	77 (30.4%)	3 (5.1%)	8.17 (2.48–26.90) 0.0001*	3.21 (0.86–11.98) 0.082	54 (36.7%)	26 (15.8%)	3.14 (1.81–5.31) 0.0001*	2.10 (1.12–3.94) 0.020*
⩽30	176 (69.6%)	56 (94.9%)	8.17 (2.48–26.90) 0.0001*	3.21 (0.86–11.98) 0.082	93 (63.3%)	139 (84.2%)	3.14 (1.81–5.31) 0.0001*	2.10 (1.12–3.94) 0.020*
Education level
Bachelor and above (Ref)	124 (49.0%)	28 (47.5%)	1.10 (0.59–2.06) 0.762	0.95 (0.47–1.93) 0.896	71 (48.3%)	81 (49.1%)	0.94 (0.57–1.53) 0.799	0.72 (0.41–1.25) 0.244
Preparatory level^a	129 (51.0%)	31 (52.5%)	1.10 (0.59–2.06) 0.762	0.95 (0.47–1.93) 0.896	76 (51.7%)	84 (50.9%)	0.94 (0.57–1.53) 0.799	0.72 (0.41–1.25) 0.244
Specialization
Health Science (Ref)	68 (26.9%)	13 (22.0%)	0.86 (0.40–1.86) 0.708	1.54 (0.67–3.55) 0.306	48 (32.7%)	33 (20.0%)	2.01 (1.14–3.64) 0.016*	3.46 (1.73–6.91) 0.0001*
Other	185 (73.1%)	46 (78.0%)	0.86 (0.40–1.86) 0.708	1.54 (0.67–3.55) 0.306	99 (67.3%)	132 (80.0%)	2.01 (1.14–3.64) 0.016*	3.46 (1.73–6.91) 0.0001*
Marital status
Married (Ref)	161 (63.6%)	7 (11.9%)	9.03 (3.80–21.50) 0.0001*	2.64 (1.01–6.91) 0.047*	103 (70.1%)	65 (39.4%)	2.05 (1.23–3.43) 0.0006*	1.13 (0.51–2.40) 0.804
Unmarried	92 (36.4%)	52 (88.1%)	9.03 (3.80–21.50) 0.0001*	2.64 (1.01–6.91) 0.047*	44 (29.9%)	100 (60.6%)	2.05 (1.23–3.43) 0.0006*	1.13 (0.51–2.40) 0.804
Experience of pregnancy
Yes (Ref)	153 (60.5%)	0 (0.0%)	<0.0001*	−	107 (72.8%)	46 (27.9%)	6.92 (4.20–11.38) 0.0001*	6.70 (3.09–14.53) 0.0001*
No	100 (39.5%)	59 (100.0%)	<0.0001*	−	40 (27.2%)	119 (72.1%)	6.92 (4.20–11.38) 0.0001*	6.70 (3.09–14.53) 0.0001*

FA: folic acid; OR: odds ratio; CI: confidence interval; AOR: adjusted odds ratio.

One-year course in university to teach students English, basic mathematics, and computer application.

p-value < 0.05 considered significant.

FA usage among respondents was assessed across different pregnancy statuses, that is, ongoing pregnancy, planning pregnancy, and non-pregnant. Of the participants who were pregnant or planning to be pregnant, only 61.1% with ongoing pregnancy and 44.4% who were planning pregnancy reported actively taking FA supplements (Figure 1).

Knowledge about the usage of FA

The respondents who were aware of FA supplementation were assessed for their knowledge of FA usage and natural sources. No significant difference was observed between the demographic characteristics of the total study population (312 respondents) and the 253 respondents specifically assessed for their knowledge of FA usage except for their marital status.

Table 4 presents the respondents’ knowledge about the usage of FA. The highest correct responses were received regarding knowledge about natural sources of FA (151, 59.7%). Furthermore, 97 (38.3%) participants had a “poor” level of knowledge. The most common source of information about the usage of FA reported by respondents was health professionals and organizations (79, 31.2%).

Table 4.

Distribution of knowledge of folic acid usage among the respondents who were aware of folic acid, n = 253.

Variable	Total respondents (n = 253)
Variable	Frequency (n)	Percentage (%)
Folic acid deficiency during pregnancy leads to:
Correct response	115	45.4
Incorrect response	138	54.6
Timing of folic acid supplementation during pregnancy to prevent NTDs
Correct response	120	47.4
Incorrect response	95	37.6
I don’t know	38	15.0
Recommended dosage of folic acid supplement during pregnancy
Correct response	145	57.3
Incorrect response	33	13.0
I don’t know	75	29.7
Natural sources of folic acid
Correct response	151	59.7
I don’t know	102	40.3
Total knowledge score
⩽2 (poor)	97	38.3
3 (fair)	72	28.5
4 (good)	84	33.2
Source of information
Family and friends	20	7.9
Internet and social media	25	9.9
Healthcare professionals and organizations	79	31.2
Multiple sources	129	51.0

Correct responses: folic acid deficiency during pregnancy leads to—neural tube defects or spinal cord defects; timing of folic acid supplementation during pregnancy to prevent NTDs—3 months before conception and during the first 3 months of pregnancy; recommended dosage of folic acid supplement during pregnancy—400 mcg once a day; natural sources of folic acid—fruits and leafy vegetables.

Unadjusted and adjusted (for all five demographic variables) ORs with 95% CIs for knowledge about usage of FA supplements are presented in Table 5. A bachelor’s and above education level was found to be an independent factor associated with the correct knowledge of FA deficiency leading to NTDs (AOR (95% CI) = 2.03 (1.17–3.52); p = 0.012), and health sciences specialization was found to be an independent factor associated with the correct knowledge of natural sources of FA (AOR (95% CI) = 2.33 (1.25–4.36); p = 0.008). Similarly, marriage was found to be an independent factor associated with correct knowledge of dosage of FA along with the timing of FA supplementation to prevent NTDs (AOR (95% CI) = 6.34 (3.50–11.48); p = 0.0001 and AOR (95% CI) = 3.45 (1.93–6.16); p = 0.0001, respectively). The experience of pregnancy was found to be an independent factor associated with good total knowledge about FA (AOR (95% CI) = 3.05 (1.65–5.63); p = 0.0001).

Table 5.

Association of sociodemographic factors with knowledge of folic acid usage among the respondents who were aware of folic acid, n = 253.

Demographic variables	Knowledge of FA (n = 253)
	Correctly specified FA deficiency leads to NTDs		OR(95% CI)p-value	AOR(95% CI)p-value	Correctly specified perinatal dosage of FA required		OR(95% CI)p-value	AOR(95% CI)p-value	Correctly specified timing of FA to prevent NTDs		OR(95% CI)p-value	AOR(95% CI)p-value
	Yes	No	OR(95% CI)p-value	AOR(95% CI)p-value	Yes	No	OR(95% CI)p-value	AOR(95% CI)p-value	Yes	No	OR(95% CI)p-value	AOR(95% CI)p-value
Age (years)
>30 (Ref)	30 (33.7%)	48 (29.3%)	1.23 (0.71–2.14) 0.466	1.12 (0.62–2.02) 0.715	49 (33.8%)	29 (26.9%)	1.39 (0.80–2.40) 0.238	1.15 (0.62–2.13) 0.656	38 (32.8%)	40 (29.2%)	1.18 (0.69–2.02) 0.541	0.88 (0.49–1.57) 0.656
⩽30	59 (66.3%)	116 (70.7%)	1.23 (0.71–2.14) 0.466	1.12 (0.62–2.02) 0.715	96 (66.2%)	79 (73.1%)	1.39 (0.80–2.40) 0.238	1.15 (0.62–2.13) 0.656	78 (67.2%)	97 (70.8%)	1.18 (0.69–2.02) 0.541	0.88 (0.49–1.57) 0.656
Education level
Graduate and above (Ref)	55 (61.8%)	69 (42.1%)	2.23 (1.31–3.78) 0.003*	2.03 (1.17–3.52) 0.012*	66 (45.5%)	58 (53.7%)	0.72 (0.44–1.19) 0.198	0.62 (0.35–1.09) 0.099	64 (55.2%)	60 (43.8%)	1.58 (0.96–2.60) 0.072	1.60 (0.93–2.75) 0.086
Preparatory level^a	34 (38.2%)	95 (57.9%)	2.23 (1.31–3.78) 0.003*	2.03 (1.17–3.52) 0.012*	79 (54.5%)	50 (46.3%)	0.72 (0.44–1.19) 0.198	0.62 (0.35–1.09) 0.099	52 (44.8%)	77 (56.2%)	1.58 (0.96–2.60) 0.072	1.60 (0.93–2.75) 0.086
Specialization
Health science (Ref)	32 (36.0%)	37 (22.6%)	1.93 (1.09–3.40) 0.023*	1.69 (0.92–3.09) 0.090	35 (24.1%)	34 (31.5%)	0.69 (0.40–1.21) 0.196	1.18 (0.62–2.26) 0.615	31 (26.7%)	38 (27.7%)	0.95 (0.54–1.66) 0.857	1.14 (0.62–2.11) 0.672
Other	57 (64.0%)	127 (77.4%)	1.93 (1.09–3.40) 0.023*	1.69 (0.92–3.09) 0.090	110 (75.9%)	74 (68.5%)	0.69 (0.40–1.21) 0.196	1.18 (0.62–2.26) 0.615	85 (73.3%)	99 (72.3%)	0.95 (0.54–1.66) 0.857	1.14 (0.62–2.11) 0.672
Marital status
Married (Ref)	55 (61.8%)	106 (64.6%)	0.88 (0.52–1.51) 0.654	0.98 (0.55–1.74) 0.939	117 (80.7%)	44 (40.7%)	6.07 (3.46–10.68) 0.0001*	6.34 (3.50–11.48) 0.0001*	90 (77.6%)	71 (51.8%)	3.22 (1.86–5.58) 0.0001*	3.45 (1.93–6.16) 0.0001*
Unmarried	34 (38.2%)	58 (35.4%)	0.88 (0.52–1.51) 0.654	0.98 (0.55–1.74) 0.939	28 (19.3%)	64 (59.3%)	6.07 (3.46–10.68) 0.0001*	6.34 (3.50–11.48) 0.0001*	26 (22.4%)	66 (48.2%)	3.22 (1.86–5.58) 0.0001*	3.45 (1.93–6.16) 0.0001*
Experience of pregnancy
Yes (Ref)	50 (56.2%)	109 (66.5%)	0.65 (0.38–1.10) 0.107	0.66 (0.38–1.14) 0.133	93 (64.1%)	66 (61.1%)	1.14 (0.68–1.90) 0.622	1.03 (0.58–1.81) 0.928	72 (62.1%)	87 (63.5%)	0.94 (0.56–1.57) 0.814	0.87 (0.50–1.49) 0.603
No	39 (33.5%)	55 (33.5%)	0.65 (0.38–1.10) 0.107	0.66 (0.38–1.14) 0.133	52 (35.9%)	42 (38.9%)	1.14 (0.68–1.90) 0.622	1.03 (0.58–1.81) 0.928	44 (37.9%)	50 (36.5%)	0.94 (0.56–1.57) 0.814	0.87 (0.50–1.49) 0.603
Demographic variables		Knowledge of FA (n = 253)
		Correctly specified natural sources of FA			OR (95% CI) p-value	AOR (95% CI) p-value		Total knowledge		OR (95% CI) p-value		AOR (95% CI) p-value
		Yes	No		OR (95% CI) p-value	AOR (95% CI) p-value		Yes	No	OR (95% CI) p-value		AOR (95% CI) p-value
Age (years)
>30 (Ref)		47 (32.6%)	31 (28.4%)		1.22	1.23		28 (33.3%)	50 (29.6%)	0.84		0.73 (0.39–1.34) 0.306
⩽30		97 (67.4%)	78 (71.6%)		(0.71–2.10) 0.474	(0.69–2.17) 0.486		56 (66.7%)	119 (70.4%)	(0.48–1.48) 0.553		0.73 (0.39–1.34) 0.306
Education level
Graduate and above (Ref)		74 (51.4%)	50 (45.9%)		1.25	1.05		44 (52.4%)	80 (47.3%)	1.22		1.20 (0.67–2.14) 0.539
Preparatory level^a		70 (48.6%)	59 (54.1%)		(0.76–2.05) 0.385	(0.62–1.78) 0.846		40 (47.6%)	89 (52.7%)	(0.71–2.09) 0.475		1.20 (0.67–2.14) 0.539
Specialization
Health science (Ref)		48 (33.3%)	21 (19.3%)		2.09	2.33		24 (28.6%)	45 (26.6%)	1.13		1.01 (0.53–1.94) 0.969
Other		96 (66.7%)	88 (80.7%)		(1.16–3.77) 0.014*	(1.25–4.36) 0.008*		60 (70.4%)	124 (73.4%)	(0.62–2.06) 0.694		1.01 (0.53–1.94) 0.969
Marital status
Married (Ref)		95 (66.0%)	66 (60.6%)		1.26	1.47		47 (56.0%)	114 (67.5%)	0.61		0.53 (0.23–0.89) 0.022*
Unmarried		49 (34.0%)	43 (39.4%)		(0.75–2.12) 0.375	(0.85–2.55) 0.170		37 (44.0%)	55 (32.5%)	(0.28–0.99) 0.047*		0.53 (0.23–0.89) 0.022*
Experience of pregnancy
Yes (Ref)		89 (61.8%)	70 (64.2%)		0.90	0.92		65 (77.4%)	94 (55.6%)	2.83		3.05 (1.65–5.63) 0.0001*
No		55 (38.2%)	39 (35.8%)		(0.54–1.51) 0.694	(0.54–1.56) 0.751		19 (22.6%)	75 (44.4%)	(1.55–5.16) 0.001*		3.05 (1.65–5.63) 0.0001*

FA: folic acid; OR: odds ratio; CI: confidence interval; AOR: adjusted odd ratio.

One-year course in university to teach students English, basic mathematics, and computer application.

p-value < 0.05 considered significant.

The level of knowledge of FA usage was assessed across marital and pregnancy status, that is, unmarried and never pregnant, married and never pregnant, and married with pregnancy experience. The unmarried and never pregnant respondents (17, 18.5%) showed a low level of total knowledge score, while married and never pregnant respondents showed higher levels of knowledge of FA deficiency leading to NTDs (47.1%) and knowledge of correct timing of FA supplementation (58.8%) compared to their counterparts. The married respondents with pregnancy experience showed a higher level of knowledge regarding the correct dosage of FA supplementation (78.5%), natural sources of FA (61.1%), and total knowledge score (42.4%) than their counterparts (Figure 2).

Discussion

In this study, awareness of FA supplementation was high (81.1%), the usage of FA was comparatively low (47.1%), and the total knowledge score of FA was poor (38.3%) among female SEU students in Jeddah. Further FA supplement intake was reported by 61.1% of pregnant respondents and 44.4% of respondents who were planning for pregnancy. This study found that 47.4% of respondents had knowledge of the correct timing of FA supplementation to prevent NTDs, 57.3% of respondents had knowledge of correct FA dosages, and 61.3% of respondents correctly identified the natural sources of FA. The main source through which respondents received information about FA was healthcare professionals (31.2%).

The level of awareness of FA was lower in this study than in a study from Taipei³⁰ and studies from Saudi Arabia, in which awareness ranged between 89.3% and 93.1%.^23,24,26 This discrepancy in the level of awareness of FA might be due to differences in the study population characteristics. In this study, nearly 50% of the study population was married, compared to 70%–100% in other studies. In this study, the respondents had a high level of awareness of FA as a supplement but had poor knowledge of FA deficiency leading to NTDs. These findings are consistent with those from other studies from Saudi Arabia^24,31 and other countries,^32,33 while a study done by AlAhmadi (2014) showed that a higher percentage of knowledge (71.2%) that NTDs can be reduced by FA supplementation.²⁵ In this study, although awareness of FA was high among the respondents, the usage of FA supplementation reported by respondents was low. Similar findings were reported by studies conducted in Saudi Arabia^20,21,34 and other countries.^35–38

The present findings suggest that respondents with specialization in health sciences gained knowledge through education, which helped to improve the intake of FA supplements. In this study, it was found that only pregnancy experience and not marital status are associated with the usage of FA supplements. A study on pregnancy-related health behavior among Saudi women reported that nearly 85% of pregnant Saudi women start prenatal care during the first trimester³⁹ and physicians prescribe FA supplementation, which results in higher usage of FA among pregnant women. Thus, FA supplementation in Saudi women at the time of conception is dependent mostly on fortified flour, but there lies uncertainty regarding the amount of FA consumed through it as fortification with FA is done only for flour and not for other staple foods such as rice and grains. The lack of an appropriate level of FA consumption during preconception may underlie the recent increase in NTDs in Saudi Arabia.²⁰

However, this study reports a comparatively higher intake of FA supplementation during pregnancy or pregnancy planning than previous studies from Saudi Arabia^20,21,34 and other countries that reported low percentages of FA supplementation intake in their study population, especially during the periconceptional period.^35–38 Knowledge pertaining to the proper timing of FA supplements is absolutely essential to ensure the normal development of the nervous system in infants, and to minimize the risk of NTDs. The present findings about knowledge of correct timing and dosage of FA supplementation to prevent NTD, and natural sources of FA are supported by another study from Saudi Arabia.²⁴ However, there is low precision in the estimates of the level of knowledge regarding FA dosage and timing to prevent NTDs from Saudi Arabia, as a few studies have reported lower level^26,27,40 and a few studies have reported higher levels of knowledge than this study.^25,41

According to WHO recommendations, FA supplementation should begin at the time women start planning to conceive and last until 12 weeks of gestation.⁸ Moreover, a research study also reported that the process of neurulation is usually completed by 28 days postconception before a woman realizes she is pregnant.³ Therefore, it is necessary to create awareness about FA supplement usage and its importance in reducing NTDs to married females, as in most countries, pregnancy is usually unplanned.⁹

Presently, Saudi Arabia is undergoing transformation due to improvement in education, which has led to a smaller family size among the new generation. Periconceptional intake of FA is now feasible, as the new generation is opting for family planning. Moreover, in Saudi Arabia, it is mandatory for all couples to attend premarital counseling clinics to obtain general counseling, hepatitis B and HIV screening and testing for genetic disorders.²⁰ The government can utilize these premarital counseling clinics as a center to educate couples about the importance of FA supplementation during the preconception period. Furthermore, they can give counseling to women about the dosage and timing of FA intake to reduce NTDs along with imparting information about natural sources of FA and encouraging them to consume sufficient amounts of FA either through natural sources or through supplements. This approach will help to reduce the incidence of NTDs in Saudi Arabia in the future. Moreover, the study findings support the outcomes of a number of extant studies that also reported that doctors are typically the main source of information about FA.^24,26,41

In the United States, FA education materials are promoted to the public through an annual event called Folic Awareness Week (National Birth Defects Prevention Network 2019). A similar annual event should be considered in Saudi Arabia, in which relevant stakeholders from across the country, including medical associations, healthcare workers, media organizations, and other volunteers can participate. They should conduct education programs such as public seminars focused on the importance of FA supplementation during the periconceptional period, and the timing of FA supplementation to prevent NTDs. Further advertisements through television or pamphlets describing the beneficial effects of FA supplementation and its natural source around the year can also help to expand the responsiveness of vulnerable, young, and unmarried women to the program. Public health programs and campaigns on the use of FA during the periconceptional period to prevent NTDs should be conducted regularly in high schools and universities.

Limitations

The study sample is non-representative of the population, as students were enrolled from a single branch of the university using a convenience sampling method. Therefore, the findings can only be generalized to Jeddah female university students. Second, the data collected by the participants are based on self-reporting which can lead to misclassification of outcomes; however, it is expected to be non-differential with respect to exposure. Third, demographic characteristics of the students who refused to participate were not collected for comparison with the participants who participated in the study. Finally, a pilot study was not carried out to test the validity of the questionnaire.

Conclusion

The study findings highlight the lack of awareness among female university students about the importance of FA usage in the prevention of NTDs. There is a need for annual awareness programs related to FA in universities.

Supplemental Material

sj-docx-1-smo-10.1177_20503121211059682 – Supplemental material for Folic acid awareness and usage among females at Saudi Electronic University in Jeddah, Saudi Arabia

Supplemental material, sj-docx-1-smo-10.1177_20503121211059682 for Folic acid awareness and usage among females at Saudi Electronic University in Jeddah, Saudi Arabia by Mohammed AL-Mohaithef, Hadeel Alaslani, Nargis Begum Javed and Sriram Chandramohan in SAGE Open Medicine

Footnotes

Acknowledgements

The authors express their sincere gratitude to the Deanship of Scientific Research, Saudi Electronic University, Riyadh, Kingdom of Saudi Arabia for their continuous support throughout this research.

Declaration of conflicting interests

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical approval

The study protocol was reviewed and approved by the Institutional Review Board of Saudi Electronic University (ethical approval no. 4239).

Funding

The author(s) received no financial support for the research, authorship and/or publication of this article.

Informed consent

Written informed consent was obtained from all subjects before the study.

ORCID iD

Mohammed AL-Mohaithef

Supplemental material

Supplemental material for this article is available online.

References

Chen

Zhou

, et al. Structural basis for molecular recognition of folic acid by folate receptors. Nature 2013; 500: 486.

Hibbard

Smithells

. Folic acid metabolism and human embryopathy. Lancet 1965; 1: 1254–1256.

Botto

Moore

Khoury

, et al. Neural-tube defects. N Engl J Med 1999; 341: 1509–1519.

Czeizel

Dudas

. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832–1835.

Simkiss

. Preventing neural tube defects. J Trop Pediatr 2017; 63: 85–86.

Milunsky

Jick

, et al. Multivitamins/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262: 2847–2852.

MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131–137.

World Health Organization. Periconceptional folic acid supplementation to prevent neural tube defects. https://www.who.int/elena/titles/folate_periconceptional/en/.

Busby

Abramsky

Dolk

, et al. For Eurocat Folic Acid Working Group. Preventing neural tube defects in Europe: population based study. BMJ 2005; 330: 574–575.

10.

De-Regil

Fernandez-Gaxiola

Dowswell

, et al. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev 2010; 10: CD007950.

11.

Honein

Paulozzi

Mathews

, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285: 2981–2986.

12.

Canfield

Collins

Botto

, et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res Clin Mol Teratol 2005; 73(10): 679–689.

13.

De Wals

Tairou

van Allen

, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 2007; 357: 135–142.

14.

Blencowe

Cousens

Modell

, et al. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 2010; 39(Suppl. 1): i110–i121.

15.

Atta

Fiest

Frolkis

, et al. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am J Public Health 2016; 106(1): e24–e34.

16.

Saudi Standard of Fortification. 1421H (2001) MKS/219/1981.

17.

El-Zanaty

Way

. Egypt Demographic and Health Survey 2005. Cairo: Ministry of Health and Population, National Population Council, El-zanaty and Associates, and ORC Macro, 2006.

18.

Safdar

Al-Dabbagh

Abuelieneen

, et al. Decline in the incidence of neural tube defects after the national fortification of flour (1997–2005). Saudi Med J 2007; 28(8): 1227–1229.

19.

Hakami

Majeed-Saidan

. The incidence and spectrum of central nervous system malformations in newborns over a decade (2001–2010) in the Central Region of Saudi Arabia. Saudi Med J 2011; 32(11): 1137–1142.

20.

Al Rakaf

Kurdi

Ammari

, et al. Patterns of folic acid use in pregnant Saudi women and prevalence of neural tube defects—results from a nested case–control study. Prev Med Rep 2015; 2: 572–576.

21.

Kari

Bardisi

Baitalmal

, et al. Folic acid awareness among female college students: neural tube defects prevention. Saudi Med J 2008; 29(12): 1749–1751.

22.

McWalter

Al Shmassi

Eldali

. Awareness and use of folic acid in a clinic-based Saudi pregnant population. Saudi J Med Sci 2015; 3: 141–145.

23.

Ahmad

Anam

Khalid

, et al. Perceptions of women of reproductive age about vitamin and folic acid supplements during pregnancy, Taibah University, Almadinah Almunawwarah, Kingdom of Saudi Arabia. J Taibah Univ Med Sci 2013; 8: 199–204.

24.

Alblowi

Alomayri

. Assessment of knowledge, awareness and behaviour of folic acid use among females during childbearing period in Tabuk city. Egypt J Hosp Med 2017; 70: 1242–1248.

25.

AlAhmadi

. Use of folic acid among pregnant women attending antenatal care clinic in AlHejrah primary health care center, Makkah AlMokarramah, Saudi Arabia. Int J Med Sci Public Health 2014; 3: 963–969.

26.

AbdRabou

. Awareness of folic acid intake for prevention of neural tube defects among women in Sakaka, Saudi Arabia. Int J Pharmacol 2019; 15: 274–279.

27.

AlHoly

Eideh

Epuru

, et al. Awareness of folic acid intake among women in the childbearing age in Hail region-Saudi Arabia. Food Nutr Sci 2013; 4: 49–55.

28.

Saudi Arabia Ministry of Health. Planning for pregnancy. https://www.moh.gov.sa/en/HealthAwareness/EducationalContent/wh/Pages/008.aspx.

29.

Raosoft. Sample size calculator, 2004. http://www.raosoft.com/samplesize.html.

30.

Jou

Hsu

Liu

, et al. Awareness and use of folic acid among pregnant women in Taipei. Taiwan J Obstet Gynecol 2010; 49: 306–310.

31.

AlHakeem

MMMK

. Impact of education on knowledge and use of folic acid among Saudi women. Pak J Med Sci 2012; 28: 686–690.

32.

Von Stenglin

Buchwald

Lynen

. Women’s awareness and use of folate supplements prior to and during pregnancy: a global perspective. Eur J Contracept Reprod Health Care 2010; 15: 111–112.

33.

French

Barr

Levy-Milne

. Folate intakes and awareness of folate to prevent neural tube defects: a survey of women living in Vancouver, Canada. J Am Diet Assoc 2003; 103(2): 181–185.

34.

Bukhari

Aljehani

Alzahrani

, et al. The awareness of folic acid supplements among women of child bearing age in King Abdulaziz University Hospital, Jeddah–Saudi Arabia. Int J Life Sci Sci Res 2016; 2: 592–598.

35.

Bitzer

von Stenglin

Bannemerschult

. Women’s awareness and periconceptional use of folic acid: data from a large European Survey. Int J Womens Health 2013; 5: 201–213.

36.

Kim

Hwang

, et al. Awareness, knowledge, and use of folic acid among non-pregnant Korean women of childbearing age. Nutr Res Pract 2018; 12(1): 78–84.

37.

Gun

Pyrazoglu

Ozturk

, et al. Awareness, knowledge, and use of folic acid among women: a study from Turkey. Arch Gynecol Obstet 2011; 283: 1249–1253.

38.

Bener

Al Maadid

Al-Bast

, et al. Maternal knowledge, attitude and practice on folic acid intake among Arabian Qatari women. Reprod Toxicol 2006; 21(1): 21–25.

39.

Ramisetty-Mikler

Javed

Alamri

, et al. Pregnancy-related health behavior of Saudi women and key information sources: a clinic-based study. Saudi J Health Sci 2018; 7: 132–137.

40.

Hage

Jalloul

Sabbah

, et al. Awareness and intake of folic acid for prevention of neural tube defects among Lebanese women of childbearing age. Matern Child Health J 2012; 16: 258–265.

41.

Nemri

AlAslany

Abulaban

, et al. Folate deficiency knowledge and use of folic acid among women of childbearing age in the Kingdom of Saudi Arabia: a population-based cross-sectional study. Int J Med Dev Ctries 2019; 3: 60–66.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB